Table I.
Region | Category | Year | Authors | Country | Area | Population | Age | Number affected | Diagnostic criteria | % with average IQ | Gender ratio | Prevalence/ 10 000 | 95% CI |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Europe | AD | 1966 | Lotter | UK | Middlesex | 78 000 | 8–10 | 32 | Rating scale | 15.6 | 2.6 (23/9) | 4.1 | 2.7; 5.5 |
AD | 1972 | Brask | Denmark | Aarhus County | 46 500 | 2–14 | 20 | Clinical | — | 1.4 (12/7) | 4.3 | 2.4; 6.2 | |
AD | 1976 | Wing et al. | UK | Camberwell | 25 000 | 5–14 | 17a | 24-item rating scale of Lotter | 30 | 16 (16/1) | 4.8b | 2.1; 7.5 | |
AD | 1983 | Bohman et al. | Sweden | County of Västerbotten | 69 000 | 0–20 | 39 | Rutter criteria | 20.5 | 1.6 (24/15) | 5.6 | 3.9; 7.4 | |
AD | 1984 | McCarthy et al. | Ireland | East | 65 000 | 8–10 | 28 | Kanner | — | 1.33 (16/12) | 4.3 | 2.7; 5.9 | |
AD | 1986 | Steinhausen et al. | Germany | West Berlin | 279 616 | 0–14 | 52 | Rutter | 55.8 | 2.25 (36/16) | 1.9 | 1.4; 2.4 | |
AD | 1989 | Cialdella and Mamelle | France | Rhône | 135 180 | 3–9 | 61 | DSM-III like | — | 2.3 | 4.5 | 3.4; 5.6 | |
AD | 1991 | Gillberg et al. | Sweden | South-West Gothenburg, Bohuslän | 78 106 | 4–13 | 74 | DSM-III-R | 18 | 2.7 (54/20) | 9.5 | 7.3; 11.6 | |
AD | 1992 | Fombonne and du Mazaubrun | France | 4 regions | 274 816 | 9 & 13 | 154 | Clinical-ICD-10 like | 13.3 | 2.1 (105/49) | 4.9 | 4.1; 5.7 | |
AD | 1997 | Fombonne et al. | France | 3 regions | 325 347 | 8–16 | 174 | Clinical ICD-10-like | 12.1 | 1.81 (112/62) | 5.35 | 4.6; 6.1 | |
AD | 1997 | Webb et al. | UK | South Glamorgan, Wales | 73 301 | 3–15 | 53 | DSM-III-R | — | 6.57 (46/7) | 7.2 | 5.3; 9.3 | |
AD | 1997 | Arvidsson et al. | Sweden | Mölnlycke | 1 941 | 3–6 | 9 | ICD-10 | 22.2 | 3.5 (7/2) | 46.4 | 16.1; 76.6 | |
AD | 1998 | Sponheim & Skjeldal | Norway | Akershus County | 65 688 | 3–14 | 34 | ICD-10 | 47.1c | 2.09 (23/11) | 5.2 | 3.4; 6.9 | |
AD | 1999 | Taylor et al. | UK | North Thames | 490 000 | 0–16 | 427 | ICD-10 | — | — | 8.7 | 7.9; 9.5 | |
AD | 1999 | Kadesjö et al. | Sweden | Karlstad | 826 | 6.7–7.7 | 6 | DSM-III-R/ICD-10 Gillberg criteria for AS | 50.0 | 5.0 (5/1) | 72.6 | 14.7; 130.6 | |
AD | 2000 | Baird et al. | UK | South-East Thames | 16 235 | 7 | 50 | ICD-10 | 60 | 15.7 (47/3) | 30.8 | 22.9; 40.6 | |
AD | 2000 | Powell et al. | UK | West Midlands | 25 377 | 1–5 | 62 | Clinical/ICD10/DSM-IV | — | — | 7.8 | 5.8; 10.5 | |
AD | 2000 | Kielinen et al. | Finland | North (Oulu et Lapland) | 27 572 | 5–7 | 57 | DSM-IV | 49.8d | 4.12 (156/50) | 20.7 | 15.3; 26.0 | |
AD | 2001 | Davidovitch et al. | Israel | Haifa | 26 160 | 7–11 | 26 | DSM-III-R/DSM-IV | — | 4.2 (21/5) | 10.0 | 6.6; 14.4 | |
AD | 2007 | Oliveira et al. | Portugal | Mainland and Azores | 67 795 | 6–9 | 115 | DSM-IV | 17 | 2.9 | 16.7 | 14.0; 20.0 | |
AD | 2001 | Fombonne et al. | UK | England and Wales | 10 438 | 5–15 | 27 | DSM-IV/ICD-10 | 55.5 | 8.0 (24/3) | 26.1 | 16.2; 36.0 | |
AD | 2001 | Magnússon and Saemundsen | Iceland | Whole Island | 43 153 | 5–14 | 57 | Mostly ICD-10 | 15.8 | 4.2 (46/11) | 13.2 | 9.8; 16.6 | |
AD | 2001 | Chakrabarti and Fombonne | UK | Stafford | 15 500 | 2.5–6.5 | 26 | ICD10/DSM-IV | 29.2 | 3.3 (20/6) | 16.8 | 10.3; 23.2 | |
AD | 2002 | Madsen et al. | Denmark | National register | 63 859 | 8 | 46 | ICD-10 | — | — | 7.2 | 5.0–10.0 | |
AD | 2004 | Tebruegge et al. | UK | Kent | 2 536 | 8–9 | 6 | ICD-10 | — | (6/0) | 23.7 | 9.6; 49.1 | |
AD | 2005 | Chakrabarti & Fombonne | UK | Stafford | 10 903 | 4–7 | 24 | ICD-10/DSM-IV | 33.3 | 3.8 (19/5) | 22.0 | 14.4; 32.2 | |
AD | 2006 | Gillberg et al. | Sweden | Göteborg | 32 568 | 7–12 | 115 | Gillberg's criteria | — | 3.6 (90/25) | 35.3 | 29.2; 42.2 | |
AD | 2006 | Baird et al. | UK | London (South Thames) | 56 946 | 9–10 | 81 | ICD-10 | 47 | 8.3 (≍ 72/9) | 38.9 | 29.9; 47.8 | |
AD | 2007 | Ellefsen et al. | Denmark | Faroe Islands | 7 689 | 8–17 | 12 | ICD-10 Gillberg criteria for AS | — | 3.0 (9/3) | 16.0 | 7.0; 25.0 | |
AD | 2007 | Latif and Williams | UK | Wales | 39 220 | 0–17 | 50 | Kanner | — | — | 12.7 | 9.0; 17.0 | |
AD | 2008 | Williams et al. | UK | South West (Avon) | 14 062 | 11 | 30 | ICD-10 | 86.7 | 5.0 (25/5) | 21.6 | 13.9; 29.3 | |
PDD | 2000 | Baird et al. | UK | London (South Thames) | 16 235 | 7 | 94 | ICD-10 | 60 | 15.7 (83/11) | 57.9 | 46.8; 70.9 | |
PDD | 2001 | Chakrabarti and Fombonne | UK | Stafford | 15 500 | 4–7 | 96 | ICD-10 | 74.2 | 3.8 (77/20) | 61.9 | 50.2; 75.6 | |
PDD | 2002 | Madsen et al. | Denmark | National register | — | 8 | 738 | ICD-10 | — | — | 30.0 | — | |
PDD | 2002 | Scott et al. | UK | Cambridge | 33 598 | 5–11 | 196 | ICD-10 | — | 4.0 (—) | 58.3 * | 50; 67* | |
PDD | 2004 | Tebruegge et al. | UK | Kent | 2 536 | 8–9 | 21 | ICD-10 | — | 6.0 (18/3) | 82.8 | 51.3; 126.3 | |
PDD | 2005 | Chakrabarti and Fombonne | UK | Stafford | 10 903 | 4–6 | 64 | ICD-10 | 70.2 | 6.1 (55/9) | 58.7 | 45.2; 74.9 | |
PDD | 2006 | Baird et al. | UK | South Thames | 56 946 | 9–10 | 158 | ICD-10 | 45 | 3.3 (121/37) | 116.1 | 90.4; 141.8 | |
PDD | 2006 | Harrison et al. | UK | Scotland | 134 661 | 0–15 | 443e | ICD-10, DSMIV | — | 7.0 (369/53) | 44.2 | 39.5; 48.9 | |
PDD | 2006 | Gillberg et al. | Sweden | Göteborg | 32 568 | 712 | 262 | DSM-IV | — | 3.6 (205/57) | 80.4 | 71.3; 90.3 | |
PDD | 2007 | Latif and Williams | UK | South Wales | 39 220 | 0–17 | 240 | ICD-10, DSM-IV, Kanner's & Gillberg's criteria | — | 6.8 — | 61.2 | 54; 69* | |
PDD | 2007 | Ellefsen et al. | Denmark | Faroe Islands | 7 689 | 8–17 | 41 | DSM-IV, Gillberg's criteria | 68.3 | 5.8 (35/6) | 53.3 | 36; 70 | |
PDD | 2008 | Williams et al. | UK | Avon | 14 062 | 11 | 86 | ICD-10 | 85.3 | 6.8 (75/11) | 61.9 | 48.8; 74.9 | |
PDD | 2009 | Baron—Cohen et al. | UK | Cambridge | 8 824 | 5–9 | 83 | ICD-10 | — | — | 94f | 75; 116 | |
PDD | 2011 | Brugha et al. | UK | National | 7 333 | >16 | 72 | ADOS-4 | 100% | 3.8 — | 98 | 30; 165 |
Calculated by the author.
This number corresponds to the sample described in Wing and Gould [1979].
This rate corresponds to the first published paper on this survey and is based on 12 participants amongst children aged 5 to 14 years.
In this study, mild mental retardation was combined with average IQ, whereas moderate and severe mental retardation were grouped together.
These figures apply to the whole study sample of 206 participants with an autism spectrum disorder (ASD).
Estimated using a capture-recapture analysis, the number of cases used to calculate prevalence was estimated to be 596.
Rate based on Special Education Needs register. A figure of 99/10 000 is provided from a parental and diagnostic survey. Other estimates in this study vary from 47 to 165/10 000 deriving from various assumptions made by the authors.
AD, autistic disorder; AS, Asperger syndrome; DSM, Diagnostic and Statistical Manual of Mental Disorders; ICD, International Classification of Diseases. PDD, developmental disorder.